Epilepsy Trial, Recruiting NCT05353452 Sponsor: Wake Forest University Health Sciences Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT05353452
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to sign and date a consent form agreeing to take part in the study
  • People who are willing to follow all of the study's procedures throughout the trial
  • People who have been diagnosed with post-traumatic epilepsy — meaning a neurologist has diagnosed them with epilepsy based on their clinical assessment or a brainwave test (EEG), they have a history of at least a mild traumatic brain injury (TBI), and the brain injury occurred before the epilepsy began
  • People who are experiencing symptoms of anxiety or depression above a certain level, as measured by standard questionnaires used in the study (confirm with trial site for exact score thresholds)
  • People who are already receiving neurological care at one of the participating study sites

Who may not be able to join:

  • People who are already being actively treated by a psychiatrist in a way that the study investigators do not believe would benefit from the additional support this trial offers
  • People who are currently having thoughts of suicide
  • People who have previously attempted suicide
  • People with current unstable drug or alcohol abuse problems
  • People with an unstable or worsening medical condition alongside their epilepsy
  • People who are currently taking part in another treatment or intervention research study
  • People whose cognitive difficulties would prevent them from completing anxiety and depression questionnaires, whether on paper, electronically, or through an interview

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Heidi M. Munger Clary, MD, MPH, Atrium Health Wake Forest Baptist

Phone: 336-716-7110

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 April 2023
Est. completion
19 May 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Emotional Subscale-Change in Quality of Life in Epilepsy-31(QOLIE-31)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov